Sunbit UV Measuring Device to Track Sun Behavior
Conditions
Immunosuppression - Skin Neoplasms
Conditions: official terms
Skin Neoplasms
Conditions: Keywords
sun behavior, immunosuppression, skin neoplasms, sunbit, uv sensor, uv dosimeter, solar radiation, uv exposition, uv index
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
Sunbit is a new wearable UV dosimeter to measure solar radiation in real time. The purpose of this study is to track sun behavior of patients at high risk for skin cancer, to investigate the feasibility of this prototype in daily life and to investigate the technical accuracy of the Sunbit.
Detailed Description
A total of 20 patients will be included to wear the Sunbit system during the time of 4 weeks. After this 4 weeks Sunbit will be recollected and data in the form of UV Indices will be extracted and analyzed.

Patients will be recruited in the Department of Dermatology of the University Hospital Zürich. The target population comprises patients with a high risk of melanoma and non-melanoma skin cancer, thus especially patients with an immunosuppressive therapy due to organ transplantation.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 50 Years
Gender: Both
Criteria: Inclusion Criteria:

- Age ≥ 18 years

- History of skin cancer (melanoma or NMSC) or patients with high risk of skin cancer (e.g. immunosuppressive therapy)

- Oral and written informed consent

Exclusion Criteria:

- Any medical condition that renders the patient bedridden for the duration of 2 weeks
Location
Department of Dermatology of the University Hospital Zurich
Zurich, Switzerland
Status: Recruiting
Contact: Müller, cand. med. - anna.mueller@usz.ch
Start Date
August 2014
Completion Date
August 2015
Sponsors
University of Zurich
Source
University of Zurich
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page